The Food and Drug Administration (FDA) recently limited the authorized use of the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine to people age 18 and older for whom other vaccines aren’t appropriate or accessible and those who opt for J&J because they wouldn’t otherwise get vaccinated. This updated authorization also applies to booster doses.
“We recognize that the Janssen COVID-19 vaccine still has a role in the current pandemic response in the United States and across the global community. … [This] action demonstrates the robustness of our safety surveillance systems and our commitment to ensuring that science and data guide our decisions.”
– J&J, in a statement